Vivimed Labs Limited (NSE:VIVIMEDLAB)

India flag India · Delayed Price · Currency is INR
6.98
+0.04 (0.58%)
Apr 29, 2026, 3:15 PM IST
-75.07%
Market Cap 578.74M
Revenue (ttm) 883.92M
Net Income (ttm) -349.49M
Shares Out 82.91M
EPS (ttm) -4.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 68,313
Average Volume 103,856
Open 6.94
Previous Close 6.94
Day's Range 6.78 - 7.14
52-Week Range 5.15 - 29.40
Beta 0.74
RSI 50.02
Earnings Date May 29, 2026

About Vivimed Labs

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups ... [Read more]

Sector Healthcare
Founded 1988
Employees 586
Stock Exchange National Stock Exchange of India
Ticker Symbol VIVIMEDLAB
Full Company Profile

Financial Performance

In fiscal year 2025, Vivimed Labs's revenue was 1.21 billion, a decrease of -24.15% compared to the previous year's 1.59 billion. Losses were -319.61 million, -29.67% less than in 2024.

Financial Statements

News

There is no news available yet.